National Cancer Institute - U.S. National Institutes of Health - www.cancer.govSkip navigationNational Cancer Institute - U.S. National Institutes of Health - www.cancer.govClinical Trials at NIH - Be part of the cure
National Cancer Institute - U.S. National Institutes of Health -
Clinical Trials at NIH Home

Investigator Profiles

Shivaani Kummar, M.D., F.A.C.P.

Shivaani Kummar, M.D., F.A.C.P

Medical Oncology Branch and Affiliates
Head, Early Clinical Trials Development
Office of the Director
Division of Cancer Treatment and Diagnosis

National Cancer Institute
9000 Rockville Pike
Building 31, Room 3A44
Bethesda, MD 20892

Phone: 301-435-0517
Fax: 301-496-0826

Dr. Kummar received her medical degree from Lady Hardinge Medical College, New Delhi, India, and her internal medicine residency training from Emory University, Atlanta, GA. Upon completion of her fellowship training in medical oncology and hematology from the National Institutes of Health, Bethesda, Maryland, she joined Yale Cancer Center, Yale University, New Haven, CT, as an assistant professor in medical oncology. In 2004, Dr. Kummar moved back to NCI and is currently head of the Early Clinical Trials Development in the Office of the Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute. Her research interests focus on the early development (Phase I/II trials) of novel therapies for cancer.

Dr. Kummar's Clinical Trial(s):

NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with colorectal cancer, head and neck cancer, lymphoma, sarcoma, or solid tumors. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.

Videocast/Podcast Videocast/Podcast Details:

The quality of these videocasts is dependent on the speed of your Internet connection. Many videocasts are streamed directly to your computer by software on the NIH VideoCasting Web site. Others require that you have a standalone player installed on your computer to handle the streaming. If you do not have a standalone player installed or if you are having problems viewing the videocast, please visit

CC Grand Rounds: (1) PARP Inhibitors: How Successful Have We Been in Modulating DNA Damage? (2) The Evolving Role of PARP Inhibitors in Breast and Ovarian Cancers

Speaker(s): Shivaani Kummar, MD, Head, Early Clinical Trials Development, Office of the Director, Division of Cancer Treatment and Diagnosis, NCI

Elise C. Kohn, MD, Head, Medical Ovarian Cancer Clinic, and Head, Molecular Signaling Section, Medical Oncology Branch, Center for Cancer Research, NCI

March 23, 2011

63 minutes

Some of the resources above require the use of a standalone player: Download Free RealPlayer External link—please read our disclaimer.

Back to Top
Health and Human Services National Institutes of Health National Cancer Institute